Weekly Outlook for CNX Pharma and its main components (July 13,2015 to July 17,2015)

8
D ATE : 10/07/2015 W EEKLY O UTLOOK FOR CNX P HARMA AND I TS M AIN C OMPONENTS (13/07/2015 - 17/07/2015) © EquityPandit Financial Services Pvt. Ltd. | www.equitypandit.com | [email protected] Jagrut Shah Darpan Shah Sr. Research Analyst Head - Research EquityPandit Financial Services Pvt. Ltd. 305, Trinity Business Centre, L. P. Savani Road, Surat - 395009 Gujarat An ISO 9001:2008 Certified Company www.equitypandit.com

Transcript of Weekly Outlook for CNX Pharma and its main components (July 13,2015 to July 17,2015)

Page 1: Weekly Outlook for CNX Pharma and its main components (July 13,2015 to July 17,2015)

DATE: 10/07/2015

WEEKLY OUTLOOK FOR CNX PHARMA AND

ITS MAIN COMPONENTS

(13/07/2015 - 17/07/2015)

© EquityPandit Financial Services Pvt. Ltd. | www.equitypandit.com | [email protected]

Jagrut Shah Darpan Shah Sr. Research Analyst Head - Research EquityPandit Financial Services Pvt. Ltd. 305, Trinity Business Centre, L. P. Savani Road, Surat - 395009 Gujarat

An ISO 9001:2008 Certified Company www.equitypandit.com

Page 2: Weekly Outlook for CNX Pharma and its main components (July 13,2015 to July 17,2015)

PAGE 2

© EquityPandit Financial Services Pvt. Ltd. | www.equitypandit.com | [email protected]

CNX PHARMA index closed the week on positive note gaining more than 2.0%. During the week the index managed to close above the strong resistance zone of 12300 where 100 Daily SMA was positioned. As we have suggested that the index has formed the Shooting Star pattern on Daily chart in an uptrend on 03/07/2015 and the index has to close above the levels 12350 to negate this pattern and index managed to close above the levels of 12350 during the week. If index manages to close above the levels of 12300 we may see index moving towards the levels of 12750 where trend-line resistance are positioned. As seen from the charts the index can face resistance around the zone of 12750 were trend-line is positioned. Support for the index lies in the zone of 12100 to 12300 where short term moving averages and 100 Daily SMA are positioned. Broad range for the index is seen from 12100 on downside to 12800 on upside.

CNX PHARMA

Page 3: Weekly Outlook for CNX Pharma and its main components (July 13,2015 to July 17,2015)

PAGE 3

© EquityPandit Financial Services Pvt. Ltd. | www.equitypandit.com | [email protected]

SUN PHARMA closed the week on positive note gaining around 3.5%. As we have mentioned last week that if the stock manages to close above the levels of 885 we may see stock moving towards the levels of 900 to 920 where 200 Daily SMA and upward sloping trend-line is positioned. On 10/07/2015 the stock manages to move above the resistance zone of 880 to 890 and the stock also close above the 200 Daily SMA positioned around the levels of 900. The stock is approaching towards the upward sloping trend-line resistance positioned around the levels of 920. Above the levels of 920 the stock can move to the levels of 960 where 100 Daily SMA is lying. Support for the stock is seen in the zone of 850 to 870 where short term moving averages and trend-line support are positioned. Broad range for the stock in the coming week can be 850 - 870 on lower side to 920 - 940 on upper side.

SUN PHARMA

Page 4: Weekly Outlook for CNX Pharma and its main components (July 13,2015 to July 17,2015)

PAGE 4

© EquityPandit Financial Services Pvt. Ltd. | www.equitypandit.com | [email protected]

Lupin closed the week on negative note losing around 1.5%. As we have mentioned last week that the stock is facing stiff resistance around the zone of 1900 where upward moving trend-line are positioned. If the stock manages to close above the levels of 1920 we may see huge spurt in the stock which may take the stock to the levels of 2000. This week also the stock could not manage to close above the levels of 1920 and the stock sold off to the levels of 1850. Support for the stock lies in the range of 1840 to 1860 where short term moving averages are lying. Resistance for the stock lies in the range of 1930 to 1950 where upward moving trend-line are positioned. Broad range for the stock is seen from 1850 - 1870 on downside to 1930 - 1950 on upside.

LUPIN

Page 5: Weekly Outlook for CNX Pharma and its main components (July 13,2015 to July 17,2015)

PAGE 5

© EquityPandit Financial Services Pvt. Ltd. | www.equitypandit.com | [email protected]

Dr Reddy closed the week on positive note gaining more than 4.5%. As we have mentioned last week that if the stock manages to close above the levels of 3610 we may see stock moving towards the levels of 3700 and the stock hit the high of 3770 dur-ing the week. The stock can face minor resistance around the levels of 3810 where earlier high is posi-tioned. Support for the stock lies in the zone of 3650 to 3700 where short term moving averages are positioned. Broad range for the stock is seen from 3670 - 3700 on downside to 3800 - 3850 on upside.

DR . REDDY

Page 6: Weekly Outlook for CNX Pharma and its main components (July 13,2015 to July 17,2015)

PAGE 6

© EquityPandit Financial Services Pvt. Ltd. | www.equitypandit.com | [email protected]

CIPLA closed the week on positive note gaining around 2.5%. As we have mentioned last week if the stock manages to close above the levels of 635 where 50 Daily EMA is positioned we may see stock moving towards the levels of 650 where 200 Daily SMA is lying. The stock hit the high of 658.65 during the week. If the stock manages to close above the levels of 650 we may see stock moving towards the levels of 665 where 100 Daily SMA is lying. Support for the stock lies in the zone of 620 to 640 where short term moving averages are positioned. Broad range for the stock is seen in the range of 610 - 630 on downside to 660 - 680 on up-side.

CIPLA

Page 7: Weekly Outlook for CNX Pharma and its main components (July 13,2015 to July 17,2015)

PAGE 7

© EquityPandit Financial Services Pvt. Ltd. | www.equitypandit.com | [email protected]

About EquityPandit

EquityPandit was established in year 2005. Today, EquityPandit is one of the Leading Equity Research Company in India, with around 33400 active subscribers around the globe, who enjoy huge profits in association with EquityPandit. We have been in this industry for a LONG time. In fact, we were among the First few Indian entities in the Advisory domain to venture onto the Inter-net. Today, we have subscribers... in 32 countries worldwide who trust us! We are an ISO Certified company for quality of our services. We were the First Company to bring research and advisory based on Tech-nical analysis on internet in India, until then, only investment research was available on internet in India.

Disclaimer: The recommendations made herein do not constitute an offer to sell or a solicitation to buy any of the securities mentioned. No representations can be made that the recommendations contained herein will be profitable or that they will not result in losses. Readers using the information contained herein are solely responsible for their actions. Information is obtained from sources deemed to be reliable but is not guaranteed as to accuracy and completeness. Minimum amount mentioned here depends upon stock prices and market conditions and will vary accordingly.

Page 8: Weekly Outlook for CNX Pharma and its main components (July 13,2015 to July 17,2015)

PAGE 8

© EquityPandit Financial Services Pvt. Ltd. | www.equitypandit.com | [email protected]

EquityPandit Premium Services

EP-F&O Special is EquityPandit’s huge profits generating package. In this service we provide you with an ex-cellent F&O calls in equity and Indexes like Nifty and bank Nifty. This service is basically for F&O Traders. Here you will receive 2-4 calls daily. Huge profits are earned every month. In this package we provide huge profits every month on consistent basis. Our subscribers earn huge profits every month.

EP-Basic is Intraday Package which is meant for intraday traders. Calls are provided live during market hours by SMS. 2-3 Intraday calls are given within a day. EquityPandit provides assured daily profits in this package i.e everyday you would end up with profits. High accuracy of 90-95% is maintained consistently. Know more

EP-Investor is EquityPandit's Flagship product. This package is for short term investments. Recommenda-tions given in this package are midcap and smallcap multibaggers. Each and every call provided in this package gives 15-25% profits in short term and most of our call gives more than 100% profits in small time duration. A most famous and appreciated package among investors in Indian Stock Market. Know more about EP-Investor